Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
specialists. To help keep you up-to-date with the latest advances worldwide on all aspects of drug therapy and management of cardiovascular disorders, this section of the journal brings you information selected from the drug therapy reporting service Inpharma Weekly . The following reports are selected from the latest issues, summarizing the most important research and development news, clinical studies, treatment guidelines, pharmacoeconomic and adverse reaction news, and expert opinion pieces published across a broad range of literature sources. 1 Inpharma Weekly provides rapid alerts to news on drugs and drug therapy. Summarizing information selected from over 1600 biomedical journals, this newsletter is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details. The use of tradenames, identified by [’~’] or the use of a registered ( ) or trade mark (™), is for product identification purposes only and does not imply endorsement. 140 1. Long-term, Low-intensity Warfarin Prevents 2. Thrombolytics: CPR Should Not Be Recurrent Venous Thromboembolism (VTE) a Contraindication Thrombolytic treatment should not be withheld in patients who Long-term low-intensity warfarin therapy is "a highly effective have experienced a cardiac arrest and received CPR as a
American Journal of Cardiovascular Drugs – Springer Journals
Published: Sep 20, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.